10835 Road to the Cure
San Diego , CA 92121
San Diego , CA 92121
Executive/
Director
Links
Price
- Last Close
-
$ 2.73
$ +0.03 1.11 %
Jan 3, 2025
- 52-Week High/Low
- $3.15 - $1.67
- YTD
- 8.5%
- Trading Volume
- 39,673
- Market Cap Full
- $ 412.5M
- Shares Outstanding
-
151.1M
Nov 2, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | - | - | -44.3% | -30.2% | -4.2% | 8.6% |
| Q2 | - | - | - | - | - | - | -35.2% | -8.3% | 7.4% | - |
| Q3 | - | - | - | - | - | 14.9% | 40% | -28.6% | -10.8% | - |
| Q4 | - | - | - | - | - | -22.9% | -44.7% | 10.4% | -18.9% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8.6% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -21.6% | 42.5% | -14.3% | -12.3% | 41.9% | -8.7% | 35.8% | -10.8% | - | - | - | -12.8% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | -72% | -51% | 18% | 9% |
Earnings
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Q1 | -0.81 | -0.31 | -0.22 |
| Q2 | -1.2 | -0.3 | -0.21 |
| Q3 | -0.46 | -0.29 | -0.20 |
| Q4 | 0.62 | -1.09 | - |
| A | -1.9 | -2 | -0.63 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Mar | - | 121.6 | 150.6 |
| Jun | - | 121.9 | 150.8 |
| Sep | 121.2 | 122.1 | 151 |
| Dec | 121.3 | 122.4 | 151.1 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Asset Management | |||||
| Inventory / Stock Turnover | - | - | - | - | - |
| Total Asset Turnover | - | - | - | - | - |
| Fixed Asset Turnover | - | - | - | - | - |
| Leverage | |||||
| Debt Ratio | - | - | - | - | - |
| Debt – Equity Ratio | - | - | - | - | - |
| Interest Coverage | 61.8 | 62.5 | 15.6 | - | - |
| Equity multiplier | 0.1 | 0.1 | - | - | - |